These two researchers have been running a full-scale clinical trial of ipilimumab, an antibody that stimulates patients' immune systems to kill tumours.
他们对单克隆抗体ipilimumab进行了全面的临床研究,ipilimumab是刺激患者免疫系统进而杀灭癌症细胞的一种抗体。
Initial trials of PLX4032 suggest it may be as good as, or even better than, ipilimumab at improving sufferers' survival. A full-scale, double-blind trial is now under way.
最初的PLX4032的试验证明它在延长患者生命方面同ipilimumab一样好,甚至比ipilimumab更好,全规模的双盲试验目前正在进行中。
应用推荐